文献速递淋巴瘤白血病

流式细胞术评估TRBC1/2偏斜作为HTLV-1感染细胞克隆性的替代标志物

Flow cytometric assessment of T-cell receptor β-chain constant region 1/2 skewing as a surrogate marker for clonality in human T-cell leukaemia virus type-1-infected cells.
PubMed 文献 · Br J Haematol · 2026-10-16

本研究开发了一种结合HAS-Flow与TRBC1/2染色的流式细胞术替代检测(HAS-TRBC法),用于评估HTLV-1感染细胞的T细胞克隆性。分析了53例HTLV-1感染者(无症状携带者25例、HAM患者4例、ATL患者24例),发现优势TRBC比值在ATL中显著高于非ATL,可有效区分ATL与非ATL(AUC 0.913,95%CI 0.803-1.000,p<0.0001),并与疾病进展标志物及两种独立整合位点克隆性检测相关。

要点

  • HAS-TRBC法可简单、经济地替代基因分析评估HTLV-1感染细胞克隆性。
  • 优势TRBC比值有效区分ATL与非ATL,AUC为0.913(95%CI 0.803-1.000,p<0.0001)。
  • 优势TRBC比值与异常淋巴细胞负荷、前病毒载量、sIL-2R及整合位点克隆性相关。

核心结论

  • HAS-TRBC法检测HTLV-1感染细胞中TRBC1/2偏斜,可作为估计T细胞克隆性的简单、经济替代方法,具有临床潜力。

研究设计与样本

  • 研究共分析53例HTLV-1感染者,包括无症状携带者25例、HTLV-1相关脊髓病4例和ATL患者24例。
  • 采用HAS-Flow方法识别HTLV-1感染细胞,并结合TRBC1/2染色量化优势TRBC比值。

主要发现

  • 优势TRBC比值在ATL中显著高于非ATL病例。
  • 优势TRBC比值区分ATL与非ATL的AUC为0.913(95%CI 0.803-1.000,p<0.0001)。
  • 优势TRBC比值与异常淋巴细胞负荷、前病毒载量、可溶性白细胞介素-2受体水平相关。
  • 优势TRBC比值与两种独立HTLV-1整合位点克隆性检测(viral integration site和RAISING-CLOVA)的结果相关。

关键数值与推荐

  • 优势TRBC比值区分ATL与非ATL的AUC为0.913(95%CI 0.803-1.000,p<0.0001)。

临床怎么用

  • HAS-TRBC法可作为简单、经济的替代方法,用于估计HTLV-1感染细胞中的T细胞克隆性。
  • 该方法有望辅助ATL的风险评估和诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Estimating T-cell clonality within human T-cell leukaemia virus type 1 (HTLV-1)-infected cell populations may aid risk assessment and diagnosis of adult T-cell leukaemia/lymphoma (ATL). However, direct assessment of HTLV-1 integration-site clonality requires genetic analyses that are costly and labour-intensive. We developed a simple flow cytometric surrogate assay by combining the HTLV-1 analysis system by flow cytometry (HAS-Flow) method, which efficiently identifies HTLV-1-infected cells, with T-cell receptor β-chain constant region (TRBC1/2) staining. We analysed 53 HTLV-1-infected individuals, including asymptomatic carriers (n = 25), patients with HTLV-1-associated myelopathy (n = 4) and patients with ATL (n = 24). TRBC1/2 skewing was quantified using the dominant TRBC ratio. The dominant TRBC ratio was significantly higher in ATL than in non-ATL cases and effectively discriminated ATL from non-ATL cases (Area under the receiver operating characteristic curve [AUC], 0.913; 95% confidence interval, 0.803-1.000; p < 0.0001). It correlated with established markers of disease progression, including abnormal lymphocyte burden, proviral load and soluble interleukin-2 receptor levels, as well as clonality assessed by two independent HTLV-1 integration-site-based methods (viral integration site and RAISING-CLOVA). These findings indicate that assessment of TRBC1/2 skewing in HTLV-1-infected cells (HAS-TRBC method) is a simple, cost-effective surrogate for estimating T-cell clonality within HTLV-1-infected cell populations, with potential clinical utility.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Jimbo K, Rowan AG, Usui M, et al. Flow cytometric assessment of T-cell receptor β-chain constant region 1/2 skewing as a surrogate marker for clonality in human T-cell leukaemia virus type-1-infected cells. Br J Haematol. 2026. PMID: 42885517. doi:10.1111/bjh.70889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。